BioSpace News Archive

Technavio analysts forecast the global vitiligo therapeutics market to grow at a CAGR of over 4% during the forecast period, according to their latest market research report.

By genetically manipulating and removing the most common mutant form of the p53 gene that promotes colorectal cancer in humans, an international team of scientists demonstrated that this therapy reduces tumor growth and tissue invasion.

MedTech Outlook publishes an annual listing of the Top 10 companies that are at the forefront of solving oncology challenges through technology.

Wounded Warrior Project® (WWP) is excited to announce CSX® as presenting sponsor of its new Carry Forward™ 5K fitness challenge.

Jump Simulation, a part of OSF Innovation and a collaboration of OSF HealthCare and the University of Illinois College of Medicine Peoria, has been recertified by the American College of Surgeons (ACS) as an outstanding center for simulation education.

The Academy of Nutrition and Dietetics will bring the 2018 Food & Nutrition Conference & Expo™ to Washington, D.C., October 20 to 23

Heidelberg Pharma AG (ISIN DE000A11QVV0 / WKN A11QVV / WL6) today announced that its partner Telix Pharmaceuticals Limited (“Telix”) (ASX:TLX), has submitted a Clinical Trial Application (CTA) to initiate a Phase III trial in Europe for 89Zr-DFO-girentuximab (TLX250) for the imaging of renal (kidney) cancer with Positron Emission Tomography (PET).

Nitro Circus hosted the inaugural A Night to Live Like Roner event August 2, 2018 at SeaLegs at the Beach - an action sports gathering to celebrate the life of Erik Roner, world-renowned skier, skydiver and a founding member of the Nitro Circus Crew.

Nutraceutical Corporation is pleased to announce that Dr. Raphael Kellman, MD will be advising the company in the development and promotion of its Solaray® Mycrobiome® Probiotic line of products.

Healogics Specialty Physician Care Continuum Program will increase the consistency, quality and speed of patient care through dedicated, focused physician leadership and clinical processes